TipRanks
ZyVersa Therapeutics (ZVSA)
OTHER OTC:ZVSA
US Market
ZVSA
ZyVersa Therapeutics
RESEARCH TOOLSreports
Want to see ZVSA full AI Analyst Report?

ZyVersa Therapeutics (ZVSA) Income Statement

207 Followers

ZyVersa Therapeutics Income Statement

Last quarter (Q1 2026), ZyVersa Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, ZyVersa Therapeutics's net income was $-1.79M. See ZyVersa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -6.93K$ -10.40K$ -10.40K$ -10.40K
Operating Expenses
$ 6.84M$ 9.13M$ 14.41M$ 13.82M$ 7.70M
Depreciation and Amortization
$ 0.00$ 6.93K$ 10.40K$ 9.87K$ 10.40K
EBITDA
$ -25.29M$ -9.14B$ -107.74M$ -14.43M$ -7.25M
Operating Income
$ -6.84M$ -9.14B$ -14.42M$ -13.83M$ -7.70M
Other Income/Expenses
$ -18.96M$ -283.35M$ -93.33M$ -1.03M$ -379.79K
Pretax Income
$ -25.80M$ -9.42B$ -107.75M$ -14.87M$ -8.08M
Net Income
$ -24.95M$ -9.41B$ -98.30M$ -14.05M$ -8.08M
Per Share Metrics
Basic EPS
$ -4.18$ -8.48$ -1.09K$ -930.25$ -173.66
Diluted EPS
$ -4.18$ -8.48$ -1.09K$ -930.25$ -173.66
Weighted Average Shares Outstanding
 5.96B 1.11M 97.50K 25.95K 46.55K
Weighted Average Shares Outstanding (Diluted)
 5.96B 1.11M 97.50K 25.95K 46.55K
Currency in USD

ZyVersa Therapeutics Earnings and Revenue History